Federal hemp restrictions threaten a multibillion-dollar North Carolina market, Germany considers a more permissive industrial-hemp framework, and Netflix makes a major move into global sports rights.
Tag: Streaming
Cannabis Court Fight Advances as Bedrocan Enters Bankruptcy
Federal cannabis opponents and the Justice Department proposed a timetable for a major rescheduling lawsuit, while the Netherlands’ sole medical cannabis supplier entered bankruptcy. Netflix is also reportedly preparing its largest workforce reduction since 2022.
Cannabis Strategy Shifts While Spotify Locks In Rogan
Tilray’s record revenue highlighted the growing role of beverages in cannabis-company diversification, while Washington regulators advanced a potentially important bridge between state licensing and federal requirements. Spotify also secured its flagship podcast relationship with a new multiyear Joe Rogan agreement.
DEA Opens Cannabis Registration as Medicare Hemp Fight Escalates
Federal cannabis policy moved deeper into implementation as the DEA opened specialized registration channels for medical marijuana businesses and opponents escalated a challenge to a Medicare hemp initiative. In Hollywood, Paramount completed its Warner Bros. Discovery acquisition, formally creating Skydance.
Cannabis M&A Escalates as Skydance Sets Its Power Structure
Curaleaf raised its hostile offer for Aurora Cannabis, while a cannabinoid drug developer reported progress toward an FDA veterinary pathway. In entertainment, Paramount named the leadership structure expected to oversee its combined business with Warner Bros. Discovery.
Cannabis Rescheduling Holds as Hemp Risks and Regulatory Scrutiny Grow
A federal appeals court left a limited cannabis rescheduling order in effect, Massachusetts crossed $10 billion in adult-use sales, and a new report quantified the hemp sector’s exposure to pending restrictions. Regulatory pressure also intensified around Fox’s Roku acquisition and Los Angeles wildfire insurance claims.
